When a paradoxical increase in serum galactomannan antigen during caspofungin therapy is not paradoxical after all.
Miceli
Marisa H
MH
Anaissie
Elias J
EJ
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D000946:Antigens, Fungal / Q000097:blood*; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins; D005656:Fungal Proteins / Q000627:therapeutic use; D005690:Galactose / Q000031:analogs & derivatives; D006801:Humans; D055666:Lipopeptides; D008351:Mannans / Q000097:blood* / Q000276:immunology; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D047071:beta-Glucans / Q000037:antagonists & inhibitors
D000935:Antifungal Agents; D000946:Antigens, Fungal; D054714:Echinocandins; D005656:Fungal Proteins; D055666:Lipopeptides; D008351:Mannans; D010456:Peptides, Cyclic; D047071:beta-Glucans; C012990:galactomannan; C007572:echinocandin B; D000077336:Caspofungin; D005690:Galactose